Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-20-000012 General Corporate
Debt relative to revenue 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
150.80% · OPTIONAL · VALID
Capex intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.10% · OPTIONAL · VALID
Operating cash generation 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-32.03% · OPTIONAL · VALID
Revenue growth 55th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
3.96% · CORE · VALID
Inventory pressure 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
74.72% · OPTIONAL · VALID
Gross margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
33.36% · CORE · VALID
Operating margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
12.05% · CORE · VALID
R&D intensity 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.04% · OPTIONAL · VALID
SBC intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.56% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 30.57%
Current 150.80%
Delta 120.23% Capex Intensity Increased
Previous 2.80%
Current 3.10%
Delta 0.30% Cash Generation Decreased
Previous 16.94%
Current -32.03%
Delta -48.97% Growth Increased
Previous 3.16%
Current 3.96%
Delta 0.81% Inventory Pressure Increased
Previous 17.08%
Current 74.72%
Delta 57.65% Margin Decreased
Previous 36.12%
Current 33.36%
Delta -2.76% Profitability Decreased
Previous 16.24%
Current 12.05%
Delta -4.19% R And D Intensity Increased
Previous 2.91%
Current 3.04%
Delta 0.13% Sbc Intensity Increased
Previous 0.55%
Current 0.56%
Delta 0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.